Chargement en cours...
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
The therapy of different advanced-stage malignancies with monoclonal antibodies blocking programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) signaling has had an impressive long-lasting effect in a portion of patients, but in most cases, this therapy was not successful, or a secondary resis...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486151/ https://ncbi.nlm.nih.gov/pubmed/28635644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18061331 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|